Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series

BJU International

Volumn 111, Issue 4 B, 2013, Pages

  Pichler, Martin ^a   Hutterer, Georg C ^b   Chromecki, Thomas F ^b   Jesche, Johanna ^b   Kampel Kettner, Karin ^b   Groselj Strele, Andrea ^c   Pummer, Karl ^b   Zigeuner, Richard ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Urology ^*  (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

predictive ability; prognosis; renal cell carcinoma; TNM classification

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT FAILURE; TUMOR NODE METASTASIS CLASSIFICATION SYSTEM 2002 VERSION; TUMOR NODE METASTASIS CLASSIFICATION SYSTEM 2010 VERSION;

AGED; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84875685422     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11584.x     Document Type: Article

References (20)

1. Pichler M, Hutterer GC, Chromecki TF, et al,. Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival. Int Urol Nephrol 2012; 44: 997-1004
2. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29
3. Travis WD,. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee. Histopathology 2009; 54: 3-11
4. Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH,. The process for continuous improvement of the TNM classification. Cancer 2004; 100: 1-5
5. Tan MH, Li H, Choong CV, et al,. The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma. Cancer 2011; 117: 5314-24
6. Byrd DR, Comptom CC, et al,. AJCC Staging Manual Teebse. Philadelphia, PA: Springer, 2009
7. Novara G, Matsumoto K, Kassouf W, et al,. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 2010; 57: 1064-71
8. Novara G, Ficarra V, Antonelli A, et al,. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 2010; 58: 588-95
9. Martinez-Salamanca JI, Huang WC, Millan I, et al,. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol 2011; 59: 120-7
10. Driscoll JJ, Rixe O,. Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials. Cancer J 2009; 15: 401-5
11. Kovacs G, Akhtar M, Beckwith BJ, et al,. The Heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-3
12. Pichler M, Hutterer GC, Chromecki TF, et al,. External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology. J Urol 2011; 186: 1773-7
13. Vickers AJ, Elkin EB,. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-74
14. Kikuchi S, Futawatari N, Sakuramoto S, et al,. Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer. Anticancer Res 2011; 31: 2361-5
15. Klikovits T, End A, Riedl G, Stiebler M, Dekan G, Klepetko W,. Effects of reclassification from the TNM-6 into the TNM-7 staging system in bronchoplastic resection for non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2011; 13: 29-34
16. Lee C, You D, Park J, et al,. Validation of the 2009 TNM Classification for Renal Cell Carcinoma: comparison with the 2002 TNM Classification by Concordance Index. Korean J Urol 2011; 52: 524-30
17. Veeratterapillay R, Simren R, El-Sherif A, Johnson MI, Soomro N, Heer R,. Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England. J Clin Pathol 2012; 65: 367-71
18. Kim SP, Alt AL, Weight CJ, et al,. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. J Urol 2011; 185: 2035-9
19. Waalkes S, Becker F, Schrader AJ, et al,. Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version? Eur Urol 2011; 59: 258-63
20. Guethmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B,. Metastatic potential in renal cell carcinomas